D-0420-2025 Class II Ongoing
FDA drug recall D-0420-2025 was initiated by Empower Clinic Services, LLC Dba Empower Pharmacy on May 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 8,230 vials.
Recall details
- Product Type
- Drugs
- Report Date
- May 21, 2025
- Initiation Date
- May 2, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,230 vials
Product description
Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date: 08/20/2024, Beyond Use by Date: 05/28/2025, Lot 202364.
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
USA Nationwide
Code information
Lot #: 202364, Exp 5/28/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0420-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026